These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 31892730)
1. Protein-bound uremic toxins are associated with cognitive function among patients undergoing maintenance hemodialysis. Lin YT; Wu PH; Liang SS; Mubanga M; Yang YH; Hsu YL; Kuo MC; Hwang SJ; Kuo PL Sci Rep; 2019 Dec; 9(1):20388. PubMed ID: 31892730 [TBL] [Abstract][Full Text] [Related]
2. Exploring binding characteristics and the related competition of different protein-bound uremic toxins. Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271 [TBL] [Abstract][Full Text] [Related]
3. Indole-3 acetic acid increased risk of impaired cognitive function in patients receiving hemodialysis. Lin YT; Wu PH; Lee HH; Mubanga M; Chen CS; Kuo MC; Chiu YW; Kuo PL; Hwang SJ Neurotoxicology; 2019 Jul; 73():85-91. PubMed ID: 30826344 [TBL] [Abstract][Full Text] [Related]
4. Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients. Bataille S; Pelletier M; Sallée M; Berland Y; McKay N; Duval A; Gentile S; Mouelhi Y; Brunet P; Burtey S BMC Nephrol; 2017 Jul; 18(1):251. PubMed ID: 28747155 [TBL] [Abstract][Full Text] [Related]
5. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001 [TBL] [Abstract][Full Text] [Related]
6. The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis. Lin CJ; Pan CF; Liu HL; Chuang CK; Jayakumar T; Wang TJ; Chen HH; Wu CJ Atherosclerosis; 2012 Nov; 225(1):173-9. PubMed ID: 22981405 [TBL] [Abstract][Full Text] [Related]
7. Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis. Deltombe O; Van Biesen W; Glorieux G; Massy Z; Dhondt A; Eloot S Toxins (Basel); 2015 Sep; 7(10):3933-46. PubMed ID: 26426048 [TBL] [Abstract][Full Text] [Related]
8. Indoxyl sulfate, not P-cresyl sulfate, is associated with advanced glycation end products in patients on long-term hemodialysis. Lin CJ; Lin J; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ Kidney Blood Press Res; 2015; 40(2):121-9. PubMed ID: 25833743 [TBL] [Abstract][Full Text] [Related]
9. Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study. Salarolli RT; Alvarenga L; Cardozo LFMF; Teixeira KTR; de S G Moreira L; Lima JD; Rodrigues SD; Nakao LS; Fouque D; Mafra D Int Urol Nephrol; 2021 Jun; 53(6):1231-1238. PubMed ID: 33438085 [TBL] [Abstract][Full Text] [Related]
10. Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production. Itoh Y; Ezawa A; Kikuchi K; Tsuruta Y; Niwa T Anal Bioanal Chem; 2012 Jun; 403(7):1841-50. PubMed ID: 22447217 [TBL] [Abstract][Full Text] [Related]
11. Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis. Takkavatakarn K; Wuttiputinun T; Phannajit J; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P J Nephrol; 2021 Dec; 34(6):1805-1817. PubMed ID: 33484425 [TBL] [Abstract][Full Text] [Related]
12. The relationship of indoxyl sulfate and p-cresyl sulfate with target cardiovascular proteins in hemodialysis patients. Wu PH; Lin YT; Chiu YW; Baldanzi G; Huang JC; Liang SS; Lee SC; Chen SC; Hsu YL; Kuo MC; Hwang SJ Sci Rep; 2021 Feb; 11(1):3786. PubMed ID: 33589722 [TBL] [Abstract][Full Text] [Related]
13. Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor. Madero M; Cano KB; Campos I; Tao X; Maheshwari V; Brown J; Cornejo B; Handelman G; Thijssen S; Kotanko P Clin J Am Soc Nephrol; 2019 Mar; 14(3):394-402. PubMed ID: 30755453 [TBL] [Abstract][Full Text] [Related]
14. Improved dialysis removal of protein-bound uremic toxins by salvianolic acids. Li J; Wang Y; Xu X; Cao W; Shen Z; Wang N; Leng J; Zou N; Shang E; Zhu Z; Guo J; Duan J Phytomedicine; 2019 Apr; 57():166-173. PubMed ID: 30772752 [TBL] [Abstract][Full Text] [Related]
15. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure. Lin CJ; Wu V; Wu PC; Wu CJ PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073 [TBL] [Abstract][Full Text] [Related]
16. Effect of sucroferric oxyhydroxide on gastrointestinal microbiome and uremic toxins in patients with chronic kidney disease undergoing hemodialysis. Iguchi A; Yamamoto S; Oda A; Tanaka K; Kazama JJ; Saeki T; Yamazaki H; Ishioka K; Suzutani T; Narita I Clin Exp Nephrol; 2020 Aug; 24(8):725-733. PubMed ID: 32285213 [TBL] [Abstract][Full Text] [Related]
17. Association between Protein-Bound Uremic Toxins and Asymptomatic Cardiac Dysfunction in Patients with Chronic Kidney Disease. Chinnappa S; Tu YK; Yeh YC; Glorieux G; Vanholder R; Mooney A Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30563136 [TBL] [Abstract][Full Text] [Related]